Agensys initiates Phase I renal cancer trial - Trading Markets (press release) PDF Print
Trading Markets (press release)The single-agent, Phase I, open-label, dose-escalation study will evaluate the safety and tolerability of AGS-16M8F in patients with renal cancer and

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.